FMR CORP 13D and 13G filings for Rigel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-12 08:21 am Sale |
2023-06-09 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
FMR CORP | 20,082 0.115% |
-869,119 (-97.74%) |
Filing |
| 2023-02-09 12:31 pm Sale |
2023-02-09 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
FMR CORP | 889,201 5.144% |
-659,458 (-42.58%) |
Filing |
| 2022-10-11 09:03 am Sale |
2022-10-07 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
FMR CORP | 1,548,659 8.960% |
-908,501 (-36.97%) |
Filing |
| 2022-02-09 10:24 am Purchase |
2022-02-08 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
FMR CORP | 2,457,159 14.368% |
365,849 (+17.49%) |
Filing |
| 2021-02-08 10:31 am Sale |
2021-02-05 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
FMR CORP | 2,091,310 12.375% |
-192,796 (-8.44%) |
Filing |